Minocycline is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Par Pharmaceutical, Inc.. The primary component is Minocycline Hydrochloride.
| Product ID | 49884-511_232d306e-6974-4a52-b615-c624bdb4a7a4 |
| NDC | 49884-511 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Minocycline |
| Generic Name | Minocycline |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2003-04-16 |
| Marketing End Date | 2024-03-31 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA065131 |
| Labeler Name | Par Pharmaceutical, Inc. |
| Substance Name | MINOCYCLINE HYDROCHLORIDE |
| Active Ingredient Strength | 50 mg/1 |
| Pharm Classes | Tetracycline-class Drug [EPC], Tetracyclines [CS] |
| NDC Exclude Flag | N |
| Marketing Start Date | 2003-04-16 |
| Marketing End Date | 2024-03-31 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA065131 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2003-04-16 |
| Ingredient | Strength |
|---|---|
| MINOCYCLINE HYDROCHLORIDE | 50 mg/1 |
| SPL SET ID: | 37baf13f-cc65-44a1-93d9-e5213875af1a |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 42291-589 | Minocycline | Minocycline |
| 42291-591 | Minocycline | Minocycline |
| 49884-511 | Minocycline | Minocycline |
| 49884-512 | Minocycline | Minocycline |
| 49884-513 | Minocycline | Minocycline |
| 57664-854 | Minocycline | Minocycline Hydrochloride |
| 57664-855 | Minocycline | Minocycline Hydrochloride |
| 57664-856 | Minocycline | Minocycline Hydrochloride |
| 63629-2228 | Minocycline | Minocycline |
| 63629-2229 | Minocycline | Minocycline |
| 69489-201 | AMZEEQ | Minocycline |
| 72356-101 | AMZEEQ | Minocycline |
| 69489-212 | ZILXI | Minocycline |
| 72356-103 | ZILXI | Minocycline |